Hvivo PLC (HVO) Share Price & Analysis

Open: 7.25
High: 7.36
Low: 6.80
Close: 6.95
Change: -0.45 (-6.21%)
Volume: 990,728

9 Jun 2026	Annual Report and Accounts (to 2025-12-31)
1 Oct 2025	Annual Report and Accounts (to 2024-12-31)
8 Oct 2024	Annual Report and Accounts (to 2023-12-31)

Shaun ChilternChief Executive Officer

–

Dr Yamin Mohammed KhanChief Executive Officer (CEO)

3 yrs 4 mos

Stephen Mark PinkertonChief Financial Officer (CFO)

3 yrs 7 mos

Thomas ForstChief Medical Officer

–

Andrew CatchpoleChief Scientific Officer (CSO)

–

Industry: Health Care
Sector: Health Care
LEI: 2138003PFXHA22YPN676
Region: Europe
Admission date: 14 Dec 2012
Website: hvivo.com
X: @hVIVO_UK

Shares in issue: 688,401,079
Total Voting Rights: 688,401,079

Last updated: 26 June 2026

Open: 7.25
High: 7.36
Low: 6.80
Close: 6.95
Change: -0.45 (-6.21%)
Volume: 990,728

9 Jun 2026	Annual Report and Accounts (to 2025-12-31)
1 Oct 2025	Annual Report and Accounts (to 2024-12-31)
8 Oct 2024	Annual Report and Accounts (to 2023-12-31)

Shaun ChilternChief Executive Officer

–

Dr Yamin Mohammed KhanChief Executive Officer (CEO)

3 yrs 4 mos

Stephen Mark PinkertonChief Financial Officer (CFO)

3 yrs 7 mos

Thomas ForstChief Medical Officer

–

Andrew CatchpoleChief Scientific Officer (CSO)

–

Industry: Health Care
Sector: Health Care
LEI: 2138003PFXHA22YPN676
Region: Europe
Admission date: 14 Dec 2012
Website: hvivo.com
X: @hVIVO_UK

Shares in issue: 688,401,079
Total Voting Rights: 688,401,079

Last updated: 26 June 2026

ISIN: GB00B9275X97
Exchange: AIMX
Market: Aim
Market Segment: ASQ1
Market Sector: AMQ1

ISIN: GB00B9275X97
Exchange: AIMX
Market: Aim
Market Segment: ASQ1
Market Sector: AMQ1

9 Jun 2026	07:00:03	Holding(s) in Company
1 Jun 2026	12:00:00	Consultancy contract with Decoy Therapeutics
29 May 2026	07:00:04	Grant of awards under Long Term Incentive Plan
20 May 2026	07:00:06	Capital Markets Day

2 Jun 2026	hVIVO win with Decoy Therapeutics signals shift towards broader contract research market, says broker	Proactive Investors
20 May 2026	S&U, 88 Energy, Serval Resources, Shoe Zone, hVIVO - Small Cap Snapshot	Proactive Investors

9 Jun 2026	07:00:03	Holding(s) in Company
1 Jun 2026	12:00:00	Consultancy contract with Decoy Therapeutics
29 May 2026	07:00:04	Grant of awards under Long Term Incentive Plan
20 May 2026	07:00:06	Capital Markets Day

2 Jun 2026	hVIVO win with Decoy Therapeutics signals shift towards broader contract research market, says broker	Proactive Investors
20 May 2026	S&U, 88 Energy, Serval Resources, Shoe Zone, hVIVO - Small Cap Snapshot	Proactive Investors

Hvivo PLC

Hvivo PLC

Price Chart

Recent RNS announcements

Annual Reports

Directors (11)

In the Press

Company details

Shares details

Instrument details